Safety and Efficacy of Iodine-131 Anti-B1 Antibody for NHL Patients With Greater Than 25% Bone Marrow Involvement

Clinical trial NCT00022906 · UNKNOWN

Trial details

NCT number: NCT00022906
Sponsor: Corixa Corporation
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Non-Hodgkin's Lymphoma

Start date: 1999-05-01
Enrollment: 24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.